SCHEMBL24762233

SCHEMBL24762233

CC(C)(C)OC(=O)N1CCC(C(F)(F)c2ccc(Br)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 3/20 0.47
▸ GPR119 Q8TDV5 5/20 0.47
▸ PTPN2 P17706 1/20 0.46
▸ PTPN1 P18031 1/20 0.46
▸ PTPN6 P29350 1/20 0.46
▸ RORC P51449 1/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ FPR3 P25089 1/20 0.45
▸ STS P08842 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26187054 0.93 USP30 (0.45) FPR2GPR119PTPN2PTPN1PTPN6
SCHEMBL26187095 0.93 USP30 (0.45) FPR2GPR119PTPN2PTPN1PTPN6
SCHEMBL23211982 0.90 MAPT (0.56) GPR119PTPN2PTPN1PTPN6KMT2A
SCHEMBL21752606 0.87 GPR119 (0.59) GPR119PTPN2PTPN1PTPN6RORC
SCHEMBL17541957 0.87 RORC (0.49) FPR2RORCMAPTFPR3
SCHEMBL34461283 0.85 GPR119 (0.53) GPR119PTPN2PTPN1PTPN6MAPT
SCHEMBL18321686 0.84 FPR2 (0.47) FPR2GPR119PTPN2PTPN1PTPN6
SCHEMBL24762239 0.83 STS (0.51) GPR119STS
Hydrochloric Acid SCHEMBL21382120 0.82 MAPT (0.49) GPR119PTPN2PTPN1PTPN6KMT2A
SCHEMBL18321371 0.81 GPR119 (0.46) FPR2GPR119PTPN2PTPN1PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES INC (US) 2024-06-13 — — US disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF PACSIN2, TPX2, PRSS12 FPR2 2494/4885GPR119 2371/4885PTPN2 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback